1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEKTAR THERAPEUTICS
Nektar Therapeutics XNAS: NKTR
40.18 4.20 (11.67%)
1.7M

XNAS 05 Sep, 2025 4:16 PM (EDT)

Nektar Therapeutics quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents